ES2614881T3 - Suspensión de células de mamífero que contienen trehalosa para la prevención de la formación de una embolia pulmonar - Google Patents
Suspensión de células de mamífero que contienen trehalosa para la prevención de la formación de una embolia pulmonar Download PDFInfo
- Publication number
- ES2614881T3 ES2614881T3 ES13788054.8T ES13788054T ES2614881T3 ES 2614881 T3 ES2614881 T3 ES 2614881T3 ES 13788054 T ES13788054 T ES 13788054T ES 2614881 T3 ES2614881 T3 ES 2614881T3
- Authority
- ES
- Spain
- Prior art keywords
- formation
- pulmonary embolism
- suspension
- mammalian cells
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Trehalosa o sus derivados, o una sal de los mismos, para utilizar en la prevención de la formación de una embolia pulmonar durante la administración de células de mamífero a través de un vaso sanguíneo como una suspensión.
Description
- Grupo de administración de MSC suspendidas en solución de lactato de Ringer
- 85,2% 9,4%
- Grupo de administración de MSC suspendidas en solución de lactato de Ringer que contiene trehalosa
- 62,1% 8,0%
Test de Tukey: p < 0,05 (grupo de administración de MSC suspendidas en solución salina fisiológica frente al grupo de administración de MSC suspendidas en solución de lactato de Ringer que contiene trehalosa); P = 0,1477 (grupo de administración de MSC suspendidas en solución de lactato de Ringer frente al grupo de administración de MSC
5 suspendidas en solución de lactato de Ringer que contiene trehalosa). Cada valor en la tabla representa el valor promedio de los resultados de 4 experimentos independientes.
[0043] A partir de los 2 resultados anteriores, es probable que el trasplante de MSC usando una solución libre de trehalosa dé lugar a la formación de una embolia pulmonar por la acumulación de MSC en el pulmón,
10 particularmente los vasos sanguíneos capilares del pulmón, reduzca la capacidad de absorción de oxígeno en el punto en cuestión y disminuya la presión parcial de oxígeno en sangre. Por otra parte, es probable que el trasplante de MSC usando una solución que contiene trehalosa dé lugar a la supresión de la acumulación de MSC en el pulmón (formación de embolia pulmonar), no reduzca la capacidad del pulmón para absorber oxígeno y no disminuya la presión parcial de oxígeno en sangre.
15
Aplicabilidad Industrial
[0044] La presente invención permite la prevención de la formación de una embolia pulmonar en el trasplante de células, tales como células madre (por ejemplo, MSC), y la reducción del riesgo de desarrollar una enfermedad
20 embólica pulmonar y, por lo tanto, es útil en el campo del trasplante médico en medicina regenerativa o similar, y el campo del tratamiento del cáncer.
10
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012106866A JP5432322B2 (ja) | 2012-05-08 | 2012-05-08 | トレハロース含有肺塞栓形成予防用哺乳動物細胞懸濁液 |
JP2012106866 | 2012-05-08 | ||
PCT/JP2013/002925 WO2013168403A1 (ja) | 2012-05-08 | 2013-05-02 | トレハロース含有肺塞栓形成予防用哺乳動物細胞懸濁液 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2614881T3 true ES2614881T3 (es) | 2017-06-02 |
Family
ID=49550467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES13788054.8T Active ES2614881T3 (es) | 2012-05-08 | 2013-05-02 | Suspensión de células de mamífero que contienen trehalosa para la prevención de la formación de una embolia pulmonar |
Country Status (13)
Country | Link |
---|---|
US (1) | US10265346B2 (es) |
EP (1) | EP2848683B1 (es) |
JP (1) | JP5432322B2 (es) |
KR (1) | KR20150013154A (es) |
CN (1) | CN104271735B (es) |
AU (1) | AU2013259255B2 (es) |
CA (1) | CA2872460C (es) |
ES (1) | ES2614881T3 (es) |
HK (1) | HK1205756A1 (es) |
NZ (1) | NZ701665A (es) |
SG (1) | SG11201407194XA (es) |
TW (1) | TWI577379B (es) |
WO (1) | WO2013168403A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9084720B2 (en) | 2013-05-07 | 2015-07-21 | BioBlast Pharma Ltd. | Compositions and methods for treating oculopharyngeal muscular dystrophy |
SG11201509030TA (en) | 2013-05-07 | 2015-11-27 | Bio Blast Pharma Ltd | Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose |
WO2016069173A2 (en) * | 2014-09-29 | 2016-05-06 | Cook General Biotechnology Llc | Uses of trehalose in cell suspensions |
JPWO2018123628A1 (ja) * | 2016-12-28 | 2019-10-31 | ロート製薬株式会社 | 細胞医薬組成物、疾患治療用キット及び細胞懸濁用溶液 |
WO2023038037A1 (ja) | 2021-09-08 | 2023-03-16 | 株式会社ガイアバイオメディシン | 細胞の処理方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3253131B2 (ja) | 1992-07-24 | 2002-02-04 | 洋巳 和田 | 移植臓器用溶液 |
EP0762897B1 (en) * | 1994-06-02 | 2003-04-02 | Elan Drug Delivery Limited | Method of preventing aggregation of proteins/peptides upon rehydration or thawing |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
JPH114682A (ja) * | 1997-06-16 | 1999-01-12 | Asahi Medical Co Ltd | 有核細胞保存方法、有核細胞保存用組成物及び有核細胞分離方法 |
FR2787464B1 (fr) | 1998-12-21 | 2003-01-10 | Neurotech | Compositions pharmaceutiques comprenant des cellules endotheliales immortalisees pour la detection et/ou le traitement des sources angiogeniques et tout particulierement des cancers |
US6280718B1 (en) | 1999-11-08 | 2001-08-28 | Wisconsin Alumni Reasearch Foundation | Hematopoietic differentiation of human pluripotent embryonic stem cells |
KR100682708B1 (ko) | 2001-06-08 | 2007-02-15 | 가부시키가이샤 디나벡크 겐큐쇼 | Vsv-g 슈도타입화 원숭이 면역부전 바이러스 벡터를 사용한 영장류 배아 줄기세포로의 유전자 도입 |
JP5274017B2 (ja) | 2005-10-13 | 2013-08-28 | 株式会社大塚製薬工場 | 肝臓保存液 |
KR20080097190A (ko) * | 2005-12-29 | 2008-11-04 | 안트로제네시스 코포레이션 | 태반 줄기세포의 수집과 보존을 위한 개선된 조성물과 이조성물의 이용 방법 |
JP2009296889A (ja) * | 2008-06-10 | 2009-12-24 | Foundation For Biomedical Research & Innovation | 造血幹細胞の培養方法 |
PE20110400A1 (es) | 2008-08-20 | 2011-06-22 | Anthrogenesis Corp | Composiciones mejoradas de celulas y metodos para preparar las mismas |
WO2010048628A1 (en) * | 2008-10-24 | 2010-04-29 | Indiana University Research And Technology Corporation | Methods for preventing aggregation of adipose stromal cells |
JP6027300B2 (ja) * | 2009-03-19 | 2016-11-16 | 国立大学法人岩手大学 | 細胞または臓器の保存液および保存方法 |
JP2010251273A (ja) | 2009-04-16 | 2010-11-04 | Norio Sudo | 多重管構造蛍光管 |
JP5341059B2 (ja) * | 2010-11-09 | 2013-11-13 | 株式会社大塚製薬工場 | 幹細胞懸濁液 |
-
2012
- 2012-05-08 JP JP2012106866A patent/JP5432322B2/ja active Active
-
2013
- 2013-05-02 KR KR20147030989A patent/KR20150013154A/ko active IP Right Grant
- 2013-05-02 SG SG11201407194XA patent/SG11201407194XA/en unknown
- 2013-05-02 CN CN201380023401.2A patent/CN104271735B/zh active Active
- 2013-05-02 WO PCT/JP2013/002925 patent/WO2013168403A1/ja active Application Filing
- 2013-05-02 NZ NZ701665A patent/NZ701665A/en not_active IP Right Cessation
- 2013-05-02 CA CA2872460A patent/CA2872460C/en not_active Expired - Fee Related
- 2013-05-02 US US14/398,321 patent/US10265346B2/en active Active
- 2013-05-02 AU AU2013259255A patent/AU2013259255B2/en not_active Ceased
- 2013-05-02 EP EP13788054.8A patent/EP2848683B1/en active Active
- 2013-05-02 ES ES13788054.8T patent/ES2614881T3/es active Active
- 2013-05-06 TW TW102116059A patent/TWI577379B/zh not_active IP Right Cessation
-
2015
- 2015-06-30 HK HK15106245.3A patent/HK1205756A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SG11201407194XA (en) | 2014-12-30 |
CA2872460C (en) | 2018-06-05 |
JP2013233102A (ja) | 2013-11-21 |
CN104271735A (zh) | 2015-01-07 |
AU2013259255A1 (en) | 2014-11-27 |
CA2872460A1 (en) | 2013-11-14 |
EP2848683A4 (en) | 2015-10-21 |
JP5432322B2 (ja) | 2014-03-05 |
EP2848683B1 (en) | 2016-12-21 |
US20150118196A1 (en) | 2015-04-30 |
HK1205756A1 (en) | 2015-12-24 |
KR20150013154A (ko) | 2015-02-04 |
TWI577379B (zh) | 2017-04-11 |
CN104271735B (zh) | 2017-08-04 |
TW201402136A (zh) | 2014-01-16 |
AU2013259255B2 (en) | 2018-04-05 |
NZ701665A (en) | 2016-09-30 |
WO2013168403A1 (ja) | 2013-11-14 |
EP2848683A1 (en) | 2015-03-18 |
US10265346B2 (en) | 2019-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2614881T3 (es) | Suspensión de células de mamífero que contienen trehalosa para la prevención de la formación de una embolia pulmonar | |
CY1120049T1 (el) | (2s)-ν-[(1s)-1-κυανο-2-φαινυλαιθυλ]-1,4-οξαζεπαν-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης i | |
JP2014138843A5 (es) | ||
BR112014000687A2 (pt) | reservatório de sangue de câmara dupla | |
PE20151426A1 (es) | Solucion para preservar conductos vasculares | |
WO2014021786A8 (en) | Arterial cannula which allows perfusion along opposing directions within a cannulated vessel | |
PE20140134A1 (es) | Metodos para mejorar la oxigenacion del tejido en peligro | |
Petznick et al. | Autologous plasma eyedrops prepared in a closed system: a treatment for dry eye | |
UA100883C2 (ru) | Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона | |
RU2012140269A (ru) | Добавка и медицинский контейнер для обогащенной эритроцитами жидкости | |
CL2013000021A1 (es) | Forma cristalina delta de la sal de arginina de perindoprilo; procedimiento de preparacion; composiciones farmaceuticas que la contienen; y su uso par el tratamiento de las enfermedades cardiovasculares, tales como hipertension arterial, insuficiencia cardiaca o enfermedad coronaria estable. | |
RU2018131914A (ru) | Перфузионная система | |
UA110434C2 (en) | Dosage form with controlled release and improved stability | |
RU2018108842A (ru) | Способ лечения заболевания с использованием соединения, оказывающего воздействие на гликолиз | |
BR112016006165A2 (pt) | tanque de armazenamento de sangue de recém-nascido | |
Brosnahan et al. | A44 INFECTIOUS DISEASE CHALLENGES IN THE ICU: Salmonella Aortitis: A Case Report Of Successful Medical Management | |
Lee et al. | Hypertensive Crisis During Excision of Retroperitoneal Mass in Patients with Abdominal Aortic Aneurysm-A Case Report | |
PL398967A1 (pl) | Zastosowanie kwasu loganowego w terapii jaskry | |
Omelchenko et al. | The vertebral artery syndrome: anatomy, clinical presentation & the principles of treatment | |
Min-Le Han et al. | Tetraphenylethylene immobilized metal-organic frameworks: highly sensitive fluorescent sensor for the detection of Cr_2O_7~(2-) and nitroaromatic explosives | |
Pereverzev et al. | THE EFFECT OF CITOFLAVIN ON THE ACID-BASE BLOOD BALANCE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | |
Nam | A case of severe bradycardia secondary to premature atrial beats | |
Souadkia | CHAGAS DISEASE: A BRIEF REVIEW | |
Swati Kumari | Evaluation of addition of dexmedetomidine to propofol anaesthesia for middle ear surgeries: a prospective double-blind randomized observational study | |
RU2019111348A (ru) | Способ удаления инородного тела верхнечелюстной пазухи |